Osteoporosis Drugs Market (Bisphosphonates, Calcitonin, Rank Ligand Inhibitors, Parathyroid Hormone Therapy (PTH) and Selective Estrogen Receptor Modulators (SERMs)) for Male and Female Population: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global osteoporosis drugs market is expected to reach USD 14.30 billion by 2021, growing at a CAGR of 4.0% between 2016 and 2021.

09-Nov-2016 | Number of pages: 110 | Report Code: ZMR-342 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the osteoporosis drugs market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Billion). The study includes drivers and restraints for the osteoporosis drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the osteoporosis drugs market on a global level.

In order to give the users of this report a comprehensive view on the osteoporosis drugs market, we have to include competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein drug class segments and gender segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new drug class launch, agreements, partnerships, collaborations & joint ventures, research& development, drug class and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, drug class portfolio of various companies along with patent analysis (2011-2016) bifurcated into the patent trend, patent share by company and patent analysis according to the region.

The study provides a decisive view on the osteoporosis drugs market by segmenting the market based on drug class, gender, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Based on drug class the market is segmented into bisphosphonates, calcitonin, rank ligand inhibitors, parathyroid hormone therapy (PTH) and selective estrogen receptor modulators (SERMs). Key gender market covered under this study includes male and female. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for osteoporosis drugs based on individual drug class and gender in all the regions and countries.

The report also includes detailed profiles of end players such as Novartis International AG, Eli Lilly Amgen Inc., Forteo, Novo Nordisk A/S., F. Hoffmann La Roche Ltd., and Company, Merck & Co, Inc., Actavis plc, Pfizer, Inc, and Teva Pharmaceutical Industries Ltd.

This report segments the global osteoporosis drugs market as follows:

Global Osteoporosis Drugs Market: Drug Class Segment Analysis

  • Bisphosphonates
  • Calcitonin 
  • Rank Ligand Inhibitors
  • Parathyroid Hormone Therapy (PTH) 
  • Selective Estrogen Receptor Modulators (SERMs)

Global Osteoporosis Drugs Market: Gender Segment Analysis

  • Male
  • Female

Global Osteoporosis Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Respiratory Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1464 | Report Format:

Global Respiratory Diagnostics Market: Overview People from every corner of the world may have suffered from some kind of respiratory diseases. Respiratory diseases may result in death if they are not properly diagnosed. Commonly prevalent respiratory diseases include asthma, acute respiratory i...Read More

Dermal Filler Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1449 | Report Format:

Global Dermal Filler Market: Overview Treatment for various skin related problems is done through dermal filler procedures. Removal of wrinkles, scars, skin smoothening and other procedures can be done through dermal filler procedure. Though fearing the side effects, the growth in this market ma...Read More

Curcumin Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1412 | Report Format:

Global Curcumin Market: Overview A chemical that is bright yellow in color is curcumin which is produced by some of the plants. It is found in the turmeric. They are mainly sold as food coloring, cosmetic supplement, herbal supplement, and food flavoring. The common application of the curcumin i...Read More

Point-of-Care Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1406 | Report Format:

Global Point-of-Care Diagnostics Market: Overview The point-of-care (POC) diagnostics deals with the medical devices that are used to get immediate outcomes in the investigation of the different diseases such as diabetes, cancer, cardiac diseases, and others. There are different types of POC dev...Read More

Contrast Media/Contrast Agent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1359 | Report Format:

Global Contrast Media/Contrast Agent Market: Overview To enhance the contrast of the structures or fluids inside the body contrast medium or the contrast agent is used in the medical imaging. The anatomical organs and structures are imaged better as the image contrast is increased. Thus, it is v...Read More

Choose License Type:
Latest Published Reports

View All Published Reports